NeyroblastGX - About the company
NeyroblastGX is a funded company based in Murrieta (United States), founded in 2020 by Aynun Begum. It operates as a Developer of theranostic products for neurodegenerative and infectious diseases, such as Alzheimer's and COVID-19. NeyroblastGX has raised an undisclosed amount in funding. The company has 16 active competitors, including 4 funded and 3 that have exited. Its top competitors include companies like Yecuris, Chengdu Zhongke Aoge Biotechnology and zPREDICTA.
Company Details
Developer of theranostic products for neurodegenerative and infectious diseases, such as Alzheimer's and COVID-19. It uses human induced pluripotent stem cells to generate organoids for research purposes for studying next-generation theranostic research such as screening drug, toxicity, and disease pathology.
- Website
- neyroblastgx.com
- Email ID
- *****@neyroblastgx.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2020
Location
Murrieta, United States
Stage
Funding Raised
Latest Funding Round
Investors
Ranked
9th among 16 active competitors
Employee Count
1 as on Jul 01, 2024
Sign up to download NeyroblastGX's company profile
NeyroblastGX's funding and investors
NeyroblastGX has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Apr 01, 2021 for $*****. 1 investor participated in its latest round. NeyroblastGX has 1 institutional investor.
Here is the list of recent funding rounds of NeyroblastGX:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 01, 2021 | 4445789 | Grant (prize money) | 7979157 | 9755702 | 6959694 | 8296578 |
Access funding benchmarks and valuations. Sign up today!View details of NeyroblastGX's funding rounds and investors
NeyroblastGX's founders and board of directors
Founder? Claim ProfileThe founders of NeyroblastGX is Aynun Begum. Aynun Begum is the CEO of NeyroblastGX.
Here are the details of NeyroblastGX's key team members:
- Aynun Begum: Founder & CEO of NeyroblastGX. Contact Info: 1 email address
View details of NeyroblastGX's Founder profiles and Board Members
NeyroblastGX's employee count trend
NeyroblastGX has 1 employees as of Jul 24. Here is NeyroblastGX's employee count trend over the years:
Uncover NeyroblastGX's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
NeyroblastGX's Competitors and alternates
Top competitors of NeyroblastGX include Yecuris, Chengdu Zhongke Aoge Biotechnology and zPREDICTA. Here is the list of Top 10 competitors of NeyroblastGX, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Yecuris 2007, Tualatin (United States), Acquired | Developer of humanized liver rodent model for liver biology research | $1.25M | 40/100 | |
2nd | Chengdu Zhongke Aoge Biotechnology 2005, Chengdu (China), Series A | Developer of xenotransplantation technology for research purposes | $6.97M | 36/100 | |
3rd | zPREDICTA 2014, San Jose (United States), Acquired | Provider of tumor-specific in vitro 3D models for drug development | $220K | 34/100 | |
4th | Zebrafish Lab 2015, Noain (Spain), Funding Raised | Zebrafish based services for preclinical and environmental applications | - | 29/100 | |
5th | Provider of engineered tissue focusing on human in vitro and epithelial models | - | - | 29/100 | |
6th | Patient-Derived tumor Xenograft patform offering preclinical cancer models and services for translational drug development | $765K | 29/100 | ||
7th |  Sagres Discovery 2000, Davis (United States), Deadpooled | Developer of mouse models to analyze disease-causing cancer genes | $20M | 27/100 | |
8th | Invivotek 2011, Trenton (United States), Unfunded | Integrated CRO providing drug discovery and development services from target to clinical trials | - | - | 27/100 |
9th | NeyroblastGX 2020, Murrieta (United States), Funding Raised | Developer of theranostic products for neurodegenerative and infectious diseases, such as Alzheimer's and COVID-19 | - | 25/100 | |
10th |  Anthrogen 2024, San Francisco (United States), Seed | Developer of molecular machines for human health, frontier manufacturing, society | $500K | 25/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on NeyroblastGX's competitors? Click here to see the top ones
NeyroblastGX's Investments and acquisitions
NeyroblastGX has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about NeyroblastGX
Explore our recently published companies
- Clarigo Infotech - Indore based, 2016 founded, Unfunded company
- Samerica - 2017 founded, Unfunded company
- Worthy Book - Kuala Lumpur based, 2009 founded, Unfunded company
- Sunrise Tech Ventures Sdn Bhd - Petaling Jaya based, 1997 founded, Unfunded company
- SPEENAR - New York City based, 2023 founded, Unfunded company
- Riders Publicity - Chiyoda City based, 1965 founded, Unfunded company
